Albiglutide for the Treatment of Type 2 Diabetes Mellitus: An Integrated Safety Analysis of the HARMONY Phase 3 Trials

Journal article

Bo Ahren, Molly C. Carr, Karen Murphy, Christopher Perkins, Marc S. Rendell, Jason Mallory, Timothy Wilson and Susan Johnson

Diabetes Research and Clinical Practice, Vol.126, pp.230-239

04/2017

Metrics

4 Record Views

Title: Albiglutide for the Treatment of Type 2 Diabetes Mellitus: An Integrated Safety Analysis of the HARMONY Phase 3 Trials
Creators: Bo Ahren (Author)
Molly C. Carr (Author)
Karen Murphy (Author)
Christopher Perkins (Author)
Marc S. Rendell (Author) - Creighton University
Jason Mallory (Author)
Timothy Wilson (Author)
Susan Johnson (Author)
Additional links: http://doi.org/10.1016/j.diabres.2017.02.017
Publication Details: Diabetes Research and Clinical Practice, Vol.126, pp.230-239
Number of pages: 230-239
Identifiers: 991005931460702656
Academic Unit: School of Medicine; Internal Medicine; Endocrine
Resource Type: Journal article